Sun Pharma/Taro ciclopirox shampoo recalled for impurity test failures
Taro Pharmaceuticals is recalling specific lots of Ciclopirox Shampoo 1% because the product failed quality tests for impurities and degradation at the 18-month mark. The affected lots expire January 31, 2026. No injuries have been reported.
From the FDA notice · Read the official notice ↗ · All Sun Pharmaceutical recalls
What to do
- Check if you have Ciclopirox Shampoo with lot numbers AD37059, AD37060, AD37061, AD37062, AD37065, AD37066, AD37067, or AD37068
- Stop using the product if you have an affected lot
- Return it to your pharmacy or dispose of it safely
- Contact your doctor if you have questions about treatment alternatives
Is yours affected?
Compare your label or packaging with the recalled product.
- Product
- Ciclopirox Shampoo, 1%, 120 mL, Rx only, Mfg by: Taro Pharmaceuticals Inc., Ontario, Canada; Dist. by: Taro Pharmaceuticals USA, Inc., NY 10532. NDC 51672-1351-08
- Sold in
- Nationwide
- Made for
- Adults (0 months and older)
Details
- Units affected
- 17,664 units
- Illnesses reported
- None reported
- Manufactured in
- 3 Skyline Dr, Hawthorne, NY, United States
- Classification
- Class II
- Recall number
- D-0240-2026
In the FDA's words
- Description
- Ciclopirox Shampoo, 1%, 120 mL, Rx only, Mfg by: Taro Pharmaceuticals Inc., Ontario, Canada; Dist. by: Taro Pharmaceuticals USA, Inc., NY 10532. NDC 51672-1351-08 Failed Impurity/Degradation specifications: OOS results obtained at the 18-month timepoint Lot #: AD37059, AD37060, AD37061, AD37062, AD37065, AD37066, AD37067, AD37068, expires: 1/31/2026. Distribution: Nationwide within the United States Affected quantity: 17,664 units
- Hazard
- Failed Impurity/Degradation specifications: OOS results obtained at the 18-month timepoint
More from Sun Pharmaceutical
See all- Taro Lidocaine Ointment 5% recalled for failed strength specifications
ModerateFDASep 23, 2026